NCT03796052View on ClinicalTrials.gov

Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

May 23, 2019

Primary Completion Date

December 18, 2019

Study Completion Date

December 18, 2019

Conditions
IchthyosisPruritus
Interventions
OTHER

Avena Sativa Skincare Regimen

Regimen consisting of 3 topical agents containing Avena Sativa (oat) kernel flour: a body wash (type = cosmetic), a body cream (type = cosmetic), and an anti-itch balm (type = OTC monograph drug with 0.5% Pramoxine HCl)

Trial Locations (1)

10022

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Johnson & Johnson Consumer Inc. (J&JCI)

INDUSTRY

NCT03796052 - Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients | Biotech Hunter | Biotech Hunter